SCHEMBL16257557

SCHEMBL16257557

Cc1c(Nc2ccc(Cl)c(Cl)c2)nc(C(F)(F)F)nc1C(=O)N1CCC(NC2CCOCC2)CC1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 6/20 0.60
CCR5 P51681 4/20 0.60
CYP1A2 P05177 1/20 0.40
CNR2 P34972 1/20 0.40
TYRO3 Q06418 2/20 0.37
BRAF P15056 1/20 0.37
LRRK2 Q5S007 2/20 0.36
AXL P30530 1/20 0.36
MERTK Q12866 1/20 0.36
EPHX2 P34913 1/20 0.36
RHOC P08134 1/20 0.36
RHOA P61586 1/20 0.36
BTK Q06187 1/20 0.36
GPR6 P46095 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
EPHA2 P29317 1/20 0.35
KDR P35968 1/20 0.35
EPHB4 P54760 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16257521 0.88 CCR2 (0.80) CCR2CCR5
SCHEMBL16257573 0.88 CCR2 (0.80) CCR2CCR5
SCHEMBL16257554 0.86 CCR2 (0.63) CCR2CCR5TYRO3LRRK2AXL
SCHEMBL16257561 0.84 CCR2 (0.78) CCR2CCR5MKNK2EPHA2KDR
SCHEMBL16257528 0.78 CCR2 (0.66) CCR2CCR5CNR2TYRO3EPHX2
SCHEMBL12180013 0.78 CCR2 (0.66) CCR2CCR5CNR2TYRO3EPHX2
SCHEMBL15083660 0.77 CCR2 (0.83) CCR2CCR5EPHX2EPHA2KDR
SCHEMBL15083656 0.77 CCR2 (0.83) CCR2CCR5EPHX2EPHA2KDR
SCHEMBL16257572 0.77 CCR2 (0.69) CCR2CCR5TYRO3LRRK2AXL
SCHEMBL16257525 0.76 CCR2 (0.48) CCR2CCR5CNR2BRAFEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed